A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors

Clinical trial NCT03995472 · COMPLETED

Trial details

NCT number: NCT03995472
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2020-02-14
Primary completion: 2023-01-12
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.